Exfoliative dermatitis morbus cutis inflammationis est cum rubore et scala, quae totum fere superficiem corporis adficit. Haec terminus applicatur cum 90% vel plures cutis adficitur.
Frequentissima causa erythrodermatis est exacerbatio morbi cutanei subiectae, qualia sunt psoriasis, contactum dermatitis, seborrheica dermatitis, lichen planus, pityriasis rubra pilaris aut medicamentorum reactiones, qualia sunt steroidum topicorum usus. Primaria manefestatio rarior est et in casibus lymphoma-cellis cutanei t-cellula videri solet. Quia interest ad differentiam lymphoma cellae T cutanei, a biopsy conficitur.
Erythroderma is an inflammatory skin disease with redness and scaling that affects nearly the entire cutaneous surface. This term applies when 90% or more of the skin is affected.
☆ In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
Red (burning) Skin Syndrome ― Erythema et scala in toto corpore sunt praecipua indicia Exfoliative dermatitis.
Erythroderma Rara est sed gravis conditio cutis. Dum accurata causa saepe ignota est, pharmacum reactionem vel cancer subiectam urgeri potest. Una communis cancer cum dermatitis exfoliativis coniunctus est lymphoma cutaneus T-cell, quae signa per menses vel etiam annos post condicionem cutis incipit ostendere non potuit. Fere hospitalization opus est ad primam aestimationem et curationem. Aegroti morbo pharmaco effecerunt fere bene diuturnum prospectum habent, quamquam casus sine causa manifesta tendunt ad cursum recurrentem et remittentem. Prognosis causarum cum cancro coniunctarum typice pendet quomodo cancer progreditur. Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Plerumque ostendit rubrum ruborem et flaingam super 90% corporis tegumentum. Haec conditio visibilis est signum variis quaestionibus subiectae sanitatis sicut psoriasis, scabies, vel responsio ad quaedam medicamenta. It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Frequentissima causa erythrodermatis est exacerbatio morbi cutanei subiectae, qualia sunt psoriasis, contactum dermatitis, seborrheica dermatitis, lichen planus, pityriasis rubra pilaris aut medicamentorum reactiones, qualia sunt steroidum topicorum usus. Primaria manefestatio rarior est et in casibus lymphoma-cellis cutanei t-cellula videri solet. Quia interest ad differentiam lymphoma cellae T cutanei, a biopsy conficitur.